高级检索
当前位置: 首页 > 详情页

PILLAR-2: A randomized, double-blind, placebo-controlled, phase III study of adjuvant everolimus in poor-risk diffuse large B-cell lymphoma (DLBCL).

| 认领 | 导出 |

文献详情

资源类型:
机构: [1]Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China [2]Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Lymphoma, Beijing 100871, Peoples R China [3]Hop Haut Leveque, Dept Hematol, Ctr Francois Magendie, Pessac, France [4]Nagoya Daini Red Cross Hosp, Ctr Canc Chemotherapy, Dept Hematol & Oncol, Nagoya, Aichi, Japan [5]Osaka Univ, Grad Sch Med, Dept Clin Hematol & Diagnost, Osaka, Japan [6]Yonsei Univ, Coll Med, Dept Internal Med, Div Hematol,Severance Hosp, Seoul, South Korea [7]Novartis Pharmaceut, Oncol Clin Dev, Florham Pk, NJ USA [8]Novartis Pharma AG, Oncol Clin Dev, Basel, Switzerland [9]Mayo Clin, Div Hematol, Rochester, MN USA
出处:
ISSN:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学
第一作者:
第一作者机构: [1]Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China [2]Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Lymphoma, Beijing 100871, Peoples R China [3]Hop Haut Leveque, Dept Hematol, Ctr Francois Magendie, Pessac, France [4]Nagoya Daini Red Cross Hosp, Ctr Canc Chemotherapy, Dept Hematol & Oncol, Nagoya, Aichi, Japan [5]Osaka Univ, Grad Sch Med, Dept Clin Hematol & Diagnost, Osaka, Japan [6]Yonsei Univ, Coll Med, Dept Internal Med, Div Hematol,Severance Hosp, Seoul, South Korea [7]Novartis Pharmaceut, Oncol Clin Dev, Florham Pk, NJ USA [8]Novartis Pharma AG, Oncol Clin Dev, Basel, Switzerland [9]Mayo Clin, Div Hematol, Rochester, MN USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:58356 今日访问量:7 总访问量:4825 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号